Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 64 | BES2019 | Next issue

Belgian Endocrine Society 2019

BES 2019

Hypercalcemia as a rare complication of anti-tumor necrosis factor alpha: a case-report and literature study

ea0064023 | Hypercalcemia as a rare complication of anti-tumor necrosis factor alpha: a case-report and literature study | BES2019

Hypercalcemia as a rare complication of anti-tumor necrosis factor alpha: a case-report and literature study

Simon Caerels , Sara Vandewalle , Annick Van den Bruel , Eric D Hondt , Christel Haenebalcke , Charlotte Depuydt

Introduction: (Anti-TNF-α) therapy is widely used for the treatment of inflammatory diseases. The most frequent adverse events induced by anti-TNF-α therapy are infections and malignancies. However, reports of paradoxical sarcoidosis-like reactions are on the rise in patients receiving anti-TNF-α.Clinical case: A 61-year old woman, with a medical history of sero-positive rheumatoid arthritis on Adalimumab treatment (anti-TNF-α), was r...